HCA Healthcare (NYSE:HCA) Lowered to Buy at StockNews.com

StockNews.com downgraded shares of HCA Healthcare (NYSE:HCAGet Rating) from a strong-buy rating to a buy rating in a research report report published on Monday.

A number of other research firms have also commented on HCA. Bank of America raised their price objective on shares of HCA Healthcare from $192.00 to $230.00 in a research note on Sunday, July 24th. Truist Financial raised their price objective on shares of HCA Healthcare from $208.00 to $240.00 and gave the company a buy rating in a research note on Monday, July 25th. Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $199.00 to $217.00 and gave the company an equal weight rating in a research note on Monday, October 24th. Stephens lowered their price objective on shares of HCA Healthcare from $230.00 to $220.00 and set an overweight rating on the stock in a research note on Monday, October 24th. Finally, Credit Suisse Group decreased their price target on shares of HCA Healthcare to $240.00 in a research report on Thursday, October 27th. One research analyst has rated the stock with a sell rating, two have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average price target of $235.10.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $228.99 on Monday. The company has a quick ratio of 1.17, a current ratio of 1.38 and a debt-to-equity ratio of 87.46. The firm’s 50-day moving average price is $208.41 and its two-hundred day moving average price is $202.25. HCA Healthcare has a 52-week low of $164.47 and a 52-week high of $279.02. The stock has a market capitalization of $64.74 billion, a P/E ratio of 12.94, a P/E/G ratio of 1.87 and a beta of 1.70.

HCA Healthcare (NYSE:HCAGet Rating) last released its quarterly earnings results on Friday, October 21st. The company reported $3.93 earnings per share for the quarter, missing analysts’ consensus estimates of $3.94 by ($0.01). The business had revenue of $14.97 billion for the quarter, compared to the consensus estimate of $15 billion. HCA Healthcare had a net margin of 8.99% and a negative return on equity of 118,732.40%. The business’s quarterly revenue was down 2.0% on a year-over-year basis. During the same period last year, the firm posted $4.57 EPS. As a group, sell-side analysts forecast that HCA Healthcare will post 16.96 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 28th. Shareholders of record on Wednesday, December 14th will be paid a dividend of $0.56 per share. This represents a $2.24 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Tuesday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.66%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 2,000 shares of HCA Healthcare stock in a transaction on Monday, October 24th. The shares were sold at an average price of $203.30, for a total value of $406,600.00. Following the completion of the sale, the senior vice president now owns 20,372 shares of the company’s stock, valued at approximately $4,141,627.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, SVP Phillip G. Billington sold 8,332 shares of HCA Healthcare stock in a transaction on Friday, October 28th. The shares were sold at an average price of $222.58, for a total value of $1,854,536.56. Following the transaction, the senior vice president now owns 40,652 shares in the company, valued at approximately $9,048,322.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Kathryn A. Torres sold 2,000 shares of HCA Healthcare stock in a transaction on Monday, October 24th. The stock was sold at an average price of $203.30, for a total transaction of $406,600.00. Following the completion of the transaction, the senior vice president now owns 20,372 shares in the company, valued at approximately $4,141,627.60. The disclosure for this sale can be found here. Insiders sold 30,170 shares of company stock valued at $6,700,630 in the last quarter. Company insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. RB Capital Management LLC increased its holdings in shares of HCA Healthcare by 25.9% during the 1st quarter. RB Capital Management LLC now owns 2,432 shares of the company’s stock worth $610,000 after purchasing an additional 501 shares during the period. Steward Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare by 144.6% during the 1st quarter. Steward Partners Investment Advisory LLC now owns 2,497 shares of the company’s stock worth $626,000 after purchasing an additional 1,476 shares during the period. National Asset Management Inc. increased its stake in HCA Healthcare by 13.5% in the first quarter. National Asset Management Inc. now owns 2,201 shares of the company’s stock valued at $553,000 after acquiring an additional 262 shares during the period. CapWealth Advisors LLC increased its stake in HCA Healthcare by 1.3% in the first quarter. CapWealth Advisors LLC now owns 5,936 shares of the company’s stock valued at $1,488,000 after acquiring an additional 77 shares during the period. Finally, FDx Advisors Inc. increased its stake in HCA Healthcare by 16.3% in the first quarter. FDx Advisors Inc. now owns 1,258 shares of the company’s stock valued at $315,000 after acquiring an additional 176 shares during the period. Institutional investors own 65.75% of the company’s stock.

About HCA Healthcare

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.